Product Information

MEDROXYPROGESTERONE 150 MG/ML is a generic product labeled by Mylan Institutional LLC, priced at $18.3134 per ML under NDC 67457088799. Its NADAC has been published 402 times since Dec 12, 2018.

FDA first approved this application on Oct 12, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

MEDROXYPROGESTERONE 150 MG/ML

Medroxyprogesterone Acetate
$18.3134per ML

Strength

150 mg/mL

NDC

67457088799

Classification

Generic

Dosage Form

INJECTION, SUSPENSION

Route

INTRAMUSCULAR

Effective Date

8/19/2026

Active Ingredients

MEDROXYPROGESTERONE ACETATE

Approval Type

Generic (ANDA)

FDA Application

ANDA210227

FDA Approved

10/12/2018

TE Code

AB

On Market Since

10/12/2018

Pharmacological Classes

Progesterone Congeners
Progestin

Price Statistics

The NADAC for MEDROXYPROGESTERONE 150 MG/ML has been published 402 times since Dec 12, 2018, and over the history we have for it it has declined 65.2%. The table below summarizes its recorded NADAC range and movement.

Current price$18.3134 per ML
All-time high$52.5523 (Dec 12, 2018)
All-time low$16.1873 (Jul 17, 2024)
52-week high$22.2984
52-week low$18.3134
Median price$28.7413
Average price$29.8034
Largest weekly change+50.7% (Aug 21, 2024)
Weeks tracked402
Tracking sinceDec 12, 2018

Price History

1W

N/A

1M

N/A

3M

N/A

6M

-5.1%

1Y

-17.9%

3Y

-31.3%

5Y

-42.0%

All

-65.2%

Last surveyed Aug 19, 2026 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of MEDROXYPROGESTERONE 150 MG/ML?

The current National Average Drug Acquisition Cost (NADAC) for MEDROXYPROGESTERONE 150 MG/ML, manufactured by Mylan Institutional LLC, is $18.3134 per ML (NDC 67457088799), effective Aug 19, 2026.

How has the price of MEDROXYPROGESTERONE 150 MG/ML changed over time?

Over the history we have for it, the NADAC for MEDROXYPROGESTERONE 150 MG/ML has declined 65.2%. It has been tracked across 402 weekly CMS publications since Dec 12, 2018.

What are the highest and lowest recorded NADAC prices for MEDROXYPROGESTERONE 150 MG/ML?

Since Dec 12, 2018, the NADAC for MEDROXYPROGESTERONE 150 MG/ML has ranged from a low of $16.1873 (Jul 17, 2024) to a high of $52.5523 (Dec 12, 2018), with a median of $28.7413 per ML.

Are there cheaper alternatives to MEDROXYPROGESTERONE 150 MG/ML?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MEDROXYPROGESTERONE 150 MG/ML, is $17.0951 per ML — about 7% below MEDROXYPROGESTERONE 150 MG/ML.

Who manufactures MEDROXYPROGESTERONE 150 MG/ML?

MEDROXYPROGESTERONE 150 MG/ML (NDC 67457088799) is labeled by Mylan Institutional LLC, and CMS classifies it as a generic product.